Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- University of Washington
- Cornell University
- Fundación Investigación del Cáncer Universidad de Salamanca
- Rutgers University
- University of Copenhagen
- University of Manchester
- University of Minnesota
- University of Pennsylvania
- VIB
- Virginia Tech
- Dana-Farber Cancer Institute
- George Washington University
- Indiana University
- Massachusetts Institute of Technology
- The University of Chicago
- University of Arkansas
- University of Glasgow
- University of North Carolina at Chapel Hill
- University of Utah
- Washington University in St. Louis
- Boston University
- CNRS
- California Institute of Technology
- Columbia University
- Duke University
- Francis Crick Institute
- HHMI
- Heidelberg University
- Howard Hughes Medical Institute (HHMI)
- INSERM
- Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences (formerly Institute of Genetics and Animal Biotechnology PAS)
- Michigan State University
- NOVA.id.FCT- Associação para a Inovação de Desenvolvimento da FCT
- Nencki Institute of Experimental Biology
- Northeastern University
- Stanford University
- Temple University
- Texas A&M AgriLife
- Texas A&M University
- The Ohio State University
- The University of South Dakota
- University of British Columbia
- University of California Irvine Health
- University of California, San Diego
- University of Cambridge
- University of Central Florida
- University of Colorado
- University of Foggia
- University of Freiburg (Uni Freiburg)
- University of Kansas Medical Center
- University of Maryland, Baltimore
- University of Michigan
- University of Michigan - Ann Arbor
- University of Nevada, Reno
- University of Notre Dame
- University of Texas Health Science Center San Antonio
- University of Trento
- Università di Foggia
- Washington State University
- Łukasiewicz PORT
- 50 more »
- « less
-
Field
-
module to limit exhaustion, gene editing (Crispr/Cas9, knocking…) includind in vivo CAR-T. We will also investigate new adoptive cell transfer in solid tumors using TRM or transgenic TCR (please see more
-
endocrine tumor samples, genomic sequencing technologies, state-of-the-art high throughput signaling assays, and transgenic mouse models to study genes of interest in the mouse parathyroid. The ENRG is the
-
, including tissue sectioning, immunohistochemistry, RNAscope, image analysis, PCR. Manage the transgenic mouse colony (when active), including breeding, identification, weaning, genotyping. Maintain up to date
-
the canine genome, through the analysis of available genomic data, review of the scientific literature and application of selection criteria related to genomic safety, accessibility and stability of transgene
-
on the kidney-lung, kidney-heart, and kidney-brain interorgan communication axes. We use in vitro assays, in vivo mouse injury models, transgenic mice, tissue analysis, confocal microscopy, and single cell or
-
imaging, quantitative data analysis, and the design and maintenance of transgenic C. elegans strains. As a lab manager, the candidate will oversee wet lab operations, microscopy resources, and ordering
-
focus on the kidney-lung, kidney-heart, and kidney-brain interorgan communication axes. We use in vitro assays, in vivo mouse injury models, transgenic mice, tissue analysis, confocal microscopy, and
-
histology techniques, particularly with regard to the central nervous system. Experience managing transgenic animal lines, including genotyping, setting up crosses, and analyzing resulting animals. Experience
-
, biochemistry, inducible transgenic, conditional knock-out and CRISPR generated knock-in mouse models, human iPSCs derived from patients, and state-of-the-art in vitro & in vivo imaging techniques. The PI’s
-
on chronobiology and neuroscience related research projects. Manage transgenic and knockout mouse colonies, pup weaning and genotyping. Maintain adequate inventory of laboratory supplies; order and organize